XOMA Royalty Corp. (XOMA)
XOMA Stock Price Chart
Explore XOMA Royalty Corp. interactive price chart. Choose custom timeframes to analyze XOMA price movements and trends.
XOMA Company Profile
Discover essential business fundamentals and corporate details for XOMA Royalty Corp. (XOMA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
6 Jun 1986
Employees
13.00
Website
https://www.xoma.comCEO
Owen Hughes Jr.
Description
XOMA Royalty Corp. functions as a specialist in aggregating biotechnology royalties, with its operations extending across Europe, the United States, and the Asia Pacific region. The company is dedicated to fostering advancements in human health by collaborating with biotechnology firms. Its core business model involves acquiring the anticipated future economic benefits, such as royalties and milestone payments, associated with pre-market therapeutic candidates that have already been licensed to pharmaceutical or biotechnology firms. The firm focuses its investments on early to mid-stage clinical assets, typically those in Phase 1 and 2 trials, selected for their robust commercial potential and because they are licensed to development partners. Its extensive portfolio currently encompasses around 70 distinct assets. The parent company, XOMA Corporation, established in 1981, has its main office in Emeryville, California.
XOMA Financial Timeline
Browse a chronological timeline of XOMA Royalty Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is $0.18, while revenue estimate is $13.91m.
Earnings released on 12 May 2026
EPS came in at $0.17 falling short of the estimated $0.19 by -10.53%, while revenue for the quarter reached $13.91m , beating expectations by +0.26%.
Earnings released on 18 Mar 2026
EPS came in at $0.12 surpassing the estimated -$0.13 by +192.31%, while revenue for the quarter reached $13.76m , beating expectations by +24.50%.
Earnings released on 12 Nov 2025
EPS came in at -$0.35 falling short of the estimated -$0.02 by -1.65k%, while revenue for the quarter reached $9.35m , missing expectations by -15.98%.
Earnings released on 13 Aug 2025
EPS came in at $0.48 surpassing the estimated -$0.12 by +500.00%, while revenue for the quarter reached $13.13m , beating expectations by +32.32%.
Earnings released on 13 May 2025
EPS came in at $0.06 surpassing the estimated -$0.26 by +123.08%, while revenue for the quarter reached $15.91m , beating expectations by +125.22%.
Earnings released on 17 Mar 2025
EPS came in at -$0.46 falling short of the estimated -$0.29 by -58.62%, while revenue for the quarter reached $2.34m , missing expectations by -73.22%.
Earnings released on 7 Nov 2024
EPS came in at -$0.39 surpassing the estimated -$0.44 by +11.36%, while revenue for the quarter reached $7.20m , missing expectations by -17.72%.
Earnings released on 13 Aug 2024
EPS came in at -$0.28 falling short of the estimated -$0.26 by -7.69%, while revenue for the quarter reached $11.09m , beating expectations by +32.29%.
Earnings released on 9 May 2024
EPS came in at -$0.86 falling short of the estimated -$0.71 by -21.13%, while revenue for the quarter reached $1.49m , beating expectations by +12.03%.
Earnings released on 8 Mar 2024
EPS came in at -$0.49 falling short of the estimated -$0.36 by -36.11%, while revenue for the quarter reached $1.83m , missing expectations by -49.08%.
Earnings released on 7 Nov 2023
EPS came in at -$0.60 falling short of the estimated -$0.48 by -25.00%, while revenue for the quarter reached $830.00k , missing expectations by -76.94%.
Earnings released on 8 Aug 2023
EPS came in at -$0.59 falling short of the estimated -$0.52 by -13.46%, while revenue for the quarter reached $1.66m , beating expectations by +107.25%.
Earnings released on 9 May 2023
EPS came in at -$0.98 falling short of the estimated -$0.50 by -96.00%, while revenue for the quarter reached $437.00k , missing expectations by -42.50%.
Earnings released on 9 Mar 2023
EPS came in at -$0.64 falling short of the estimated $0.47 by -236.17%, while revenue for the quarter reached $1.49m , beating expectations by +40.19%.
Earnings released on 3 Nov 2022
EPS came in at -$0.48 falling short of the estimated -$0.20 by -140.00%, while revenue for the quarter reached $451.00k , missing expectations by -90.02%.
Earnings released on 4 Aug 2022
EPS came in at -$0.53 falling short of the estimated -$0.11 by -381.82%, while revenue for the quarter reached $983.00k , missing expectations by -76.98%.
Earnings released on 5 May 2022
EPS came in at -$0.32 surpassing the estimated -$0.34 by +5.88%, while revenue for the quarter reached $3.11m , missing expectations by -1.83%.
Earnings released on 8 Mar 2022
EPS came in at $1.67 falling short of the estimated $2.27 by -26.43%, while revenue for the quarter reached $35.94m , beating expectations by +2.29%.
Earnings released on 4 Nov 2021
EPS came in at -$0.51 falling short of the estimated -$0.09 by -466.67%, while revenue for the quarter reached $940.00k , missing expectations by -63.71%.
Earnings released on 5 Aug 2021
EPS came in at -$0.31 surpassing the estimated -$0.41 by +24.39%, while revenue for the quarter reached $901.00k , missing expectations by -57.30%.
XOMA Stock Performance
Access detailed XOMA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
